However, several studies have found HSP upregulation in a number of solid tumors and hematologic malignancies, favoring tumor proliferation, invasion and metastasis, as well as protecting tumor cells from apoptosis and from anti-tumor immune response [29]. This evidence concerns the gene HSP90B2P and neoplasm.